These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14483539)

  • 1. [Effects of the administration of fava beans and primaquine on glucose-6-phosphate dehy-drogenase-deficient erythrocytes labeled with Cr-51].
    PANIZON F; VULLO C
    Haematologica; 1962; 47():205-14. PubMed ID: 14483539
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the destruction of glutathione-unstable red blood cells. The influence of fava beans and primaquine upon such cells in vivo.
    GREENBERG MS; WONG H
    J Lab Clin Med; 1961 May; 57():733-46. PubMed ID: 13708261
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Primaquine on the red blood cell membrane. II. Potassium ion permeability in glucose-6-phosphate dehydrogenase deficient erythrocytes.
    WEED RI
    J Clin Invest; 1961 Jan; 40(1):140-3. PubMed ID: 13783700
    [No Abstract]   [Full Text] [Related]  

  • 4. Charasteristics of glucose-6-phosphate dehydrogenase from normal and primaquine-sensitive erythrocytes.
    KIRKMAN HN
    Nature; 1959 Oct; 184():1291-2. PubMed ID: 14409359
    [No Abstract]   [Full Text] [Related]  

  • 5. The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes.
    SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
    J Lab Clin Med; 1959 Aug; 54():232-40. PubMed ID: 14443591
    [No Abstract]   [Full Text] [Related]  

  • 6. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
    BREWER GJ; TARLOV AR; ALVING AS
    JAMA; 1962 May; 180():386-8. PubMed ID: 13872968
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
    KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
    JAMA; 1962 May; 180():388-94. PubMed ID: 14454972
    [No Abstract]   [Full Text] [Related]  

  • 8. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.
    TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
    Arch Intern Med; 1962 Feb; 109():209-34. PubMed ID: 13919680
    [No Abstract]   [Full Text] [Related]  

  • 9. Certain aspects of carbohydrate and lipid metabolism in primaquine sensitive erythrocytes.
    CHARLTON RW; MENDELSOHN D
    S Afr J Med Sci; 1961 Dec; 26():109-14. PubMed ID: 13878293
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic deficiency in primaquine-sensitive erythrocytes.
    ALVING AS; CARSON PE; FLANAGAN CL; ICKES CE
    Science; 1956 Sep; 124(3220):484-5. PubMed ID: 13360274
    [No Abstract]   [Full Text] [Related]  

  • 11. THE MECHANISM OF HAEMOLYSIS IN FAVISM. SOME ANALOGY IN THE ACTIVITY OF PRIMAQUINE AND FAVA JUICE.
    PANIZON F; ZACCHELLO F
    Acta Haematol; 1965 Mar; 33():129-38. PubMed ID: 14326932
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes.
    KELLERMEYER RW; CARSON PE; SCHRIER SL; TARLOV AR; ALVING AS
    J Lab Clin Med; 1961 Nov; 58():715-24. PubMed ID: 14454971
    [No Abstract]   [Full Text] [Related]  

  • 13. The hemolytic effect of various sulfonamides on subjects with a deficiency of glucose-6-phosphate dehydrogenase of erythrocytes.
    SZEINBERG A; PRAS M; SHEBA C; ADAM A; RAMOT B
    Isr Med J; 1959; 18():176-83. PubMed ID: 13836343
    [No Abstract]   [Full Text] [Related]  

  • 14. GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS.
    COHEN G; HOCHSTEIN P
    Biochemistry; 1964 Jul; 3():895-900. PubMed ID: 14214074
    [No Abstract]   [Full Text] [Related]  

  • 15. IN VIVO GENERATION OF H2O2 IN MOUSE ERYTHROCYTES BY HEMOLYTIC AGENTS.
    COHEN G; HOCHSTEIN P
    J Pharmacol Exp Ther; 1965 Jan; 147():139-43. PubMed ID: 14255158
    [No Abstract]   [Full Text] [Related]  

  • 16. [STUDIES ON ERYTHROCYTES OF A GLUCOSE-6-PHOSPHATE-NADP-OXIDOREDUCTASE DEFECT].
    SCHEUCH D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1964; 82():76-85. PubMed ID: 14253329
    [No Abstract]   [Full Text] [Related]  

  • 17. The incorporation of isotopically labelled glycine into glutathione of erythrocytes with glucose-6-phosphate dehydrogenase deficiency.
    SZEINBERG A; ADAM A; RAMOT B; SHEBA C; MYERS F
    Biochim Biophys Acta; 1959 Nov; 36():65-73. PubMed ID: 13836341
    [No Abstract]   [Full Text] [Related]  

  • 18. THE SEPARATION OF GLUCOSE-6-PHOSPHATE-DEHYDROGENASE-DEFICIENT ERYTHROCYTES FROM THE BLOOD OF HETEROZYGOTES FOR GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY.
    BEUTLER E; BALUDA MC
    Lancet; 1964 Jan; 1(7326):189-92. PubMed ID: 14074498
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythrocyte glucose-6-phosphate dehydrogenase deficiency in New Guinea and New Britain.
    KIDSON C
    Nature; 1961 Jun; 190():1120-1. PubMed ID: 13755825
    [No Abstract]   [Full Text] [Related]  

  • 20. Change of deformability and Heinz body formation in G6PD-deficient erythrocytes treated with 5-hydroxy-6-desmethylprimaquine.
    Thompson SF; Fraser IM; Strother A; Bull BS
    Blood Cells; 1989; 15(2):443-52; discussion 453-4. PubMed ID: 2765673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.